Sleep Better with Sleepme AI
April 14, 2022
These days, everyone and their mother is tracking their sleep statistics yearning to get the most out of their slumber. Recent research has made clear how much sleep affects health and mood and with the COVID-19 pandemic causing a decline…
Cresco Labs Announces Strategic Acquisition of Columbia Care
April 14, 2022
One of the largest cannabis acquisitions is set to happen by the end of 2022 involving vertically integrated giants Cresco Labs and Columbia Care. On March 23, 2022, Cresco Labs announced its intent to purchase Columbia Care for a…
Patents For Treating COVID-19 With Cannabinoids Still Coming Through But Don’t Spark Up Yet
April 7, 2022
Mask mandates and other pandemic protocols might be disappearing around the US but that doesn’t mean patents are. A patent application for treating SARS-CoV-2 with an antiviral composition containing cannabinoids as the active ingredient…
States, Licensed Growers Push Back On THC Derived From Legally Grown Hemp
March 31, 2022
All around the country, THC derived from legally grown hemp is being sold in gas stations, smoke shops, and the like - with absolutely no oversight. Different forms of THC including, Delta-8 and Delta-10 THC, which are synthesized from CBD…
Aurora Cannabis to Acquire TerraFarma (Thrive Cannabis)
March 24, 2022
Aurora Cannabis is a large Canadian cannabis company that has only begun incorporating patent assets in its business since 2017 although it was founded in 2006. Compared to other industry giants like Canopy Growth, Aurora Cannabis’ patent…
Radient Technologies Innovations Rushes to Patent Cannabis Technologies
March 17, 2022
It’s not every week you see a new cannabis entrant looking to disrupt competition. The last time Patent Forecast spotted a disrupter was back in June 2021 when Nicoventures Trading Ltd. had 29 patent applications published at once.…
Small Pharma Is On A Patenting Streak
March 10, 2022
Last week, Patent Forecast highlighted London-based Small Pharma’s Phase I Trial Results for its DMT-assisted therapy for Major Depressive Disorder (MDD) treatment. With Phase II Trials on the horizon, two more patent applications (U.S.…
Breathe and Relax: CBD Aerosolizer
March 10, 2022
Inventors from the Moreau Consultant group envision a new way of consuming cannabinoids - just breathing as usual. U.S. Patent Publication 20220062569 published in early March 2022 describes a device that aerosolizes nano-emulsified…
Smart Vapes Could Be On The Horizon From Canopy Growth
March 3, 2022
In December 2018, Canopy Growth Corporation shook the world with its acquisition of the premier vaping company Storz & Bickel GmbH & Co. KG. Storz & Bickel has over 25 years of experience in the creation of exquisite…
Texas Federal Judge Tosses Canopy Growth Lawsuit
March 3, 2022
A Texas Federal judge has dismissed Canopy Growth’s patent infringement lawsuit against GW Pharmaceuticals after claim construction analysis favored GW Pharmaceuticals and both parties came to agreement that Canopy Growth could not…
Promising DMT Phase I Trial Results Released by Small Pharma
February 24, 2022
Psychedelic therapies are growing in interest across the world. In Texas, the government has begun studying the efficacy of psilocybin in treating PTSD in veterans. Now, neuroscience company, Small Pharma, Inc., has more insight into the…
Portable Cannabis Testing Market to Grow in Popularity with Increased Recreational Cultivation
February 24, 2022
Instant cannabis and hemp potency testing company GemmaCert, Ltd. received its second patent for its GemmaCert cannabis analysis products, GemmaCert Professional and GemmaCert Lite. The GemmaCert Professional and GemmaCert Lite are used to…
Can CBD Treat SARS-CoV-2 Variants? Patent Filings Say Yes
February 10, 2022
Patent Forecast has highlighted in two insights (Can CBD Obliterate COVID Variants? Hello Nasal Spray & Were You Exposed to COVID-19? Here’s What You Could Do Next.) the increase in filings for treating COVID-19 with cannabinoids,…
Cannabinoids for Cancer
January 27, 2022
Patent filings for treating cancer with cannabinoids has been on a steady increase over the past few years. Already in January 2022, two patents have been published for treating cancer with cannabinoids. Patent Forecast® highlighted GW…
Cannabis Patents You Might Not Have Expected To See
January 20, 2022
With over half of the United States having legalized some form of cannabis, the race to file patent applications has been on a steep rise. Patent Forecast® has calculated a 305% increase in patent application filings and patents in the…
Big Pharma Wants In On Cannabis
January 13, 2022
2021 ended with huge news that Pfizer would be entering the medical cannabis market with a $6.7 billion acquisition of Arena Pharmaceuticals announced in December 2021. Arena Pharmaceuticals researches and develops cannabinoid receptor…
Cultivating Interest in Athleticism-Enhancing Biologicals
January 6, 2022
The dream for a pill to naturally improve one's athletic performance is almost here. As researchers study and understand the human body and its interactions with symbiotic and parasitic microbes more and more, they can begin to take…
Cannabis-Enhanced Simulations Could Help Treat Various Psychological Disorders
January 6, 2022
An interesting patent application was published in December 2021 teaching a therapy process for psychological disorders utilizing a cannabinoid composition and an augmented reality (AR) or virtual reality (VR) experience. U.S. Patent…
CES 2022: Not Sleeping On Ring Sensors
January 6, 2022
CES 2022 is currently underway, and one of the major trends is smart rings, with both Circular and Movano showing rings. Circular analyzes biosignals to provide feedback on sleep and other daily activities. The company raised over $300,000…
Why Some Investors Aren’t Lighting Up Cannabis
December 9, 2021
Investors share vastly different opinions on cannabis but it all stems from one fundamental fact - cannabis is still illegal under federal law. The implications are quite serious and do raise more than reasonable concerns, the first being…
This Inhaler Company Could be Big Tobacco’s Next Target for Acquisition
November 18, 2021
Philip Morris International took the world by surprise when it announced it would acquire Vectura Group, an inhaler technology and platform company, in September 2021. The main concern - what is Philip Morris going to do with a company…
Verano’s Strategic Position in Florida that Could Lead it to the Top
November 18, 2021
Verano Holdings, LLC got its humble start in Illinois, privately funded with $120 million and poised to strategically consolidate operating cannabis facilities in what will help it to become one of the US’s leading multi-state operators…
What’s Philip Morris’ Intention with Vectura?
November 17, 2021
Speculations arose with the September 2021 Philip Morris International (PMI) acquisition of inhaler maker Vectura Group. Philip Morris said the acquisition is part of its long-term plan to become “smoke-free” and a “broader healthcare and…
The US Government is Interested in Psychedelics
November 17, 2021
In cooperation with Yale University, The Department of Veterans Affairs could be looking into treating mood disorders using psychedelics. Arising from NIH grant MH101498 is a patent application with claims for treating or preventing a mood…
Should the Psychedelics Industry Worry about the Compass Pathways Psilocybin Patent?
November 17, 2021
Psychedelics are becoming the new cannabis. University and private company interest has grown quickly over the last 5 years. Many companies like MindMed and NeonMind have announced their filings of provisional patent applications and are…